Latest Health News
Extendicare Announces December 2025 Dividend of C$0.042 per Share
December 12, 2025 17:00 ET | Source: Extendicare Inc. MARKHAM, Ontario, Dec.…
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025 16:30 ET | Source: Zevra Therapeutics CELEBRATION, Fla., Dec.…
Teva Releases Q4 2025 Aide Memoire
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
Milestone Receives FDA Approval of CARDAMYST (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)
First FDA approved treatment in 30+ years for more than 2 million…
Accelerating Patient Recruitment and Research Excellence: TrialWire Supports Endpoints Clinical Trials Day NYC 2025
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest,…
Genesis Healthcare Remains Committed to Securing Longterm Stability
KENNETT SQUARE, Pa., Dec. 12, 2025 (GLOBE NEWSWIRE) -- Following a court…
Sienna Announces Offering of $250 Million of 3.524% Series F Senior Unsecured Debentures and Redemption of C$175 Million of Series B Senior Unsecured Debentures
December 11, 2025 18:36 ET | Source: Sienna Senior Living NOT FOR…
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
December 11, 2025 18:25 ET | Source: Surgery Partners, Inc. BRENTWOOD, Tenn.,…
Independent Study Presented at American Society of Hematology (ASH) Annual Meeting Concludes Remestemcel-L Superior to Ruxolitinib in Clinical Outcomes as Treatment for SR-aGvHD
December 11, 2025 18:22 ET | Source: Mesoblast Limited NEW YORK, Dec.…
